310
Participants
Start Date
October 8, 2024
Primary Completion Date
December 9, 2025
Study Completion Date
December 9, 2025
AZD5004
AZD5004 film-coated tablet once daily during 36 weeks
Placebo
Placebo matching AZD5004 film-coated tablet once daily during 36 weeks
Research Site, Tainan City
Research Site, Kaohsiung City
Research Site, St Leonards
Research Site, Merewether
Research Site, St Albans
Research Site, Heidelberg
Research Site, Taipei
Research Site, Berlin
Research Site, Vestal
Research Site, Manassas
Research Site, Hamburg
Research Site, Charlottesville
Research Site, Oldenburg
Research Site, Durham
Research Site, Wilmington
Research Site, Spartanburg
Research Site, North Charleston
Research Site, Bad Oeynhausen
Research Site, Orlando
Research Site, Hialeah
Research Site, Knoxville
Research Site, Taichung
Research Site, Beachwood
Research Site, Cincinnati
Research Site, Valparaiso
Research Site, Münster
Research Site, Farmington Hills
Research Site, West Des Moines
Research Site, Fargo
Research Site, Lombard
Research Site, Chesterfield
Research Site, Sankt Ingbert
Research Site, Omaha
Research Site, Mannheim
Research Site, Dallas
Research Site, Woodway
Research Site, Houston
Research Site, Austin
Research Site, Ogden
Research Site, Chandler
Research Site, Huntington Park
Research Site, La Mesa
Research Site, Walnut Creek
Research Site, Lincoln
Research Site, Roslindale
Research Site, Calgary
Research Site, Surrey
Research Site, Victoria
Research Site, Halifax
Research Site, Guelph
Research Site, Hamilton
Research Site, Hamilton
Research Site, Toronto
Research Site, Toronto
Research Site, Terrebonne
Research Site, Suita-shi
Research Site, Blackpool
Research Site, Bristol
Research Site, Chesterfield
Research Site, Leicester
Research Site, Rotherham
Research Site, Witney
Lead Sponsor
AstraZeneca
INDUSTRY